CytoSorbents Corporation (CTSO)

[BuyMyAsk]

Does anybody remember me? I have been out of the stock for a while and posting, but have still followed the Company.

The $4.50 offering is disappointing. I am assuming the institutional market does not believe the data will be there to get FDA approval. You all have to remember that despite solid anecdotal evidence of efficiency of Cytosorb, the Company has had a tremendously difficult time collecting the positive data it needs to show statistical significant for 28 day mortality.

I may or may not buy back in. The dilution is the least of shareholder worries, as the notion that the Company is only worth $4.50, in the opinion of an institutional investor, is upsetting.

It is good sales have been increasing, but the sales figures are peanuts. If they have 100% QoQ growth that would be something else, but that is hardly the case. A few of the CEO's friends can place orders together that equate to $5mm a quarter for a large network of hospitals.

Donald Trump, who I support somewhat, has stated he looks to loosen FDA regulations, which may benefit CTSO, but that is years away IMHO.

ThoughtS?